Related Experiment Video
Updated: May 1, 2026

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
Published on: August 20, 2007
Insulin-like growth factor 2 enhances regulatory T-cell functions and suppresses food allergy in an experimental
Gui Yang1, Xiao-Rui Geng1, Jiang-Ping Song2
1ENT Institute of Shenzhen University, Shenzhen, China; Longgang Central Hospital, Shenzhen ENT Institute, Shenzhen, China.
Background:
The functions of regulatory T (Treg) cells are important in immunity, and the regulatory mechanisms of Treg cell activities are not fully understood yet.
Objectives:
We sought to investigate the role of insulin-like growth factor (IGF) 2 in the upregulation of Treg cell function.
Methods:
The expression of insulin-like growth factor 2 receptor (IGF2R) on T cells was assessed by using flow cytometry. Treg cell functions were evaluated by assessing the suppressor effect on proliferation of other effector T (Teff) cells. The effect of IGF2 on regulating Treg cell functions were evaluated with a cell-culture model and a food allergy mouse model.
Results:
Expression of IGF2R was observed in more than 90% of murine and human Treg cells but in less than 10% of effector CD4(+) T cells. Activation of IGF2R and T-cell receptor induced marked Treg cell proliferation and release of TGF-β from Treg cells, which enhanced Treg cell immune suppressor effects on other Teff cell activities and allergic inflammation in the intestine.
Conclusions:
Activation of IGF2R enhances Treg cell functions in suppressing other Teff cell activities and inhibiting allergic inflammation in the intestine.
Related Concept Videos
Type I Diabetes II: Pathophysiology
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Type II Diabetes I: Introduction

